Abstract
This review aim to demonstrate the role of bioisosterism in rational drug design as well as in the molecular modification and optimization process aiming to improve pharmacodynamic and pharmacokinetic properties of lead compounds.
Keywords: lead compound, isosterism, antagonist, pharmacodynamic, pharmacokinetic, hplc, prostaglandin-h synthase-2 (pghs-
Current Medicinal Chemistry
Title: Bioisosterism: A Useful Strategy for Molecular Modification and Drug Design
Volume: 12 Issue: 1
Author(s): Lidia Moreira Lima and Eliezer J. Barreiro
Affiliation:
Keywords: lead compound, isosterism, antagonist, pharmacodynamic, pharmacokinetic, hplc, prostaglandin-h synthase-2 (pghs-
Abstract: This review aim to demonstrate the role of bioisosterism in rational drug design as well as in the molecular modification and optimization process aiming to improve pharmacodynamic and pharmacokinetic properties of lead compounds.
Export Options
About this article
Cite this article as:
Lima Moreira Lidia and Barreiro J. Eliezer, Bioisosterism: A Useful Strategy for Molecular Modification and Drug Design, Current Medicinal Chemistry 2005; 12 (1) . https://dx.doi.org/10.2174/0929867053363540
DOI https://dx.doi.org/10.2174/0929867053363540 |
Print ISSN 0929-8673 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-533X |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
Overview of Prostate Biomarkers as Potential Targets for Immunotherapy
Current Cancer Therapy Reviews Substrate Spectra of Nucleoside Phosphorylases and their Potential in the Production of Pharmaceutically Active Compounds
Current Pharmaceutical Design Paradoxical Thrombotic Effects of Aspirin: Experimental Study on 1000 Animals
Cardiovascular & Hematological Disorders-Drug Targets New Analytical Tools for Studying Autoimmune Diseases
Current Pharmaceutical Design Combat Pneumococcal Infections: Adhesins as Candidates for Protein- Based Vaccine Development
Current Drug Targets Anti-Angiogenic Therapy in Renal Cell Carcinoma
Recent Patents on Anti-Cancer Drug Discovery Is Metformin a Therapeutic Paradigm for Colorectal Cancer: Insight into the Molecular Pathway?
Current Drug Targets A Perspective on Rational Designs of a Hemagglutinin Based Universal Influenza Vaccine
Current Pharmaceutical Design Strategies that Target Tight Junctions for Enhanced Drug Delivery
Current Pharmaceutical Design Therapeutic Potential of Nitrate Esters of Commonly Used Drugs
Current Topics in Medicinal Chemistry Multiple Sclerosis: Emerging Opportunities for Therapeutic Intervention
Current Drug Targets - CNS & Neurological Disorders Pharmacodynamics of Piroxicam from Novel Solid Lipid Microparticles Formulated with Homolipids from Bos indicus
Current Drug Delivery Regulation of the Activity of the Human Drug Metabolizing Enzyme Arylamine N-Acetyltransferase 1: Role of Genetic and Non Genetic Factors
Current Pharmaceutical Design Editorial [Hot topic: G-Protein Coupled Receptors: Drug Targets of Key Importance (Guest Editors: Luca Piali and Christoph Boss)]
Current Topics in Medicinal Chemistry RNA Interference-Based Therapeutics: New Strategies to Fight Infectious Disease
Infectious Disorders - Drug Targets CDK9: Therapeutic Perspective in HCC Therapy
Current Cancer Drug Targets Craniofacial Anomalies: From Development to Molecular Pathogenesis
Current Molecular Medicine Islet Compensation in Metabolic Stress: Lessons from Animal Models
Current Diabetes Reviews New Frontiers in the Therapeutic Management of Transplant Rejection
Current Pharmaceutical Design Potential Application of Silver Nanoparticles in Medicine
Nanoscience & Nanotechnology-Asia